Gastric Cancer Endoscopic Screening in an Intermediate‐Risk Country—A Dual‐Center Pilot Program
Helicobacter · 2025
DOI: 10.1111/hel.70061 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Helicobacter, 2025. Verfasst von M B Mourato und 6 weiteren Autor:innen. Beteiligte Einrichtung: NOVA National School of Public Health, Public Health Research Centre, Comprehensive Health Research Center, CHRC, LA-REAL, CCAL, NOVA University Lisb…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Early Detection of Cancer. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Background
Gastric cancer remains a major global health concern and is still frequently diagnosed at advanced stages in Western countries. Despite increasing evidence supporting the role of endoscopic screening in intermediate‐risk regions such as Portugal, no national program currently exists. This study aimed to evaluate the feasibility, adherence, and diagnostic yield of opportunistic upper endoscopy performed simultaneously with colorectal cancer screening. Material and Methods We conducted an observational retrospective study including individuals aged 50–74 years scheduled for a screening colonoscopy, who were invited to undergo an additional upper gastrointestinal endoscopy, between February 2023 and February 2025 in two endoscopy units in the Alentejo region of Portugal. Data regarding demographics, endoscopic findings, and histology were collected and analyzed descriptively.
Results
Of 401 individuals invited, 380 (94.8%) accepted and underwent upper endoscopy, and 377 were included in the final analysis. Histological findings included Helicobacter pylori infection (30.8%), chronic atrophic gastritis (36.9%) and intestinal metaplasia (10.1%). Regarding neoplastic lesions, 2 cases (0.5%) of low‐grade intraepithelial neoplasia, 3 cases (0.8%) of gastric adenocarcinoma, and 2 cases (0.5%) of gastrointestinal stromal tumors were identified, yielding a total malignancy rate of 1.9%; no early gastric cancers were identified. Colorectal findings included 29.2% precancerous lesions and 3.4% invasive colorectal cancer.
Conclusion
This study confirms that opportunistic upper endoscopic screening, integrated into colorectal cancer‐screening programs, is feasible, well accepted, and diagnostically valuable in an intermediate‐risk Western population. The high rate of precancerous conditions and malignant lesions detected reinforces the need for structured screening strategies. These results align with international recommendations and provide real‐world evidence to support broader implementation in similar healthcare contexts. Study Registration ClinicalTrials.gov : NCT06316882
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- NOVA National School of Public Health, Public Health Research Centre, Comprehensive Health Research Center, CHRC, LA-REAL, CCAL, NOVA University Lisbon, Lisbon, Portugal.
- Unidade Local de Saúde Do Alto Alentejo, Hospital Doutor José Maria Grande, Portalegre, Portugal.
- Hospital do Espírito Santo de Évora, Évora, Portugal.
- Instituto Português de Oncologia de Coimbra, Coimbra, Portugal.
- RISE@CI-IPO (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal.
ORCID-Profile: M B Mourato, N Pratas, A Branco Pereira, F Costa Pinto, R Dinis, I Fronteira, M Areia
Zitieren
APA
Mourato, M. B., Pratas, N., Branco Pereira, A., Costa Pinto, F., Dinis, R., Fronteira, I., & Areia, M. (2025). Gastric Cancer Endoscopic Screening in an Intermediate‐Risk Country—A Dual‐Center Pilot Program. Helicobacter. https://doi.org/10.1111/hel.70061
Vancouver
Mourato MB, Pratas N, Branco Pereira A, Costa Pinto F, Dinis R, Fronteira I, et al. Gastric Cancer Endoscopic Screening in an Intermediate‐Risk Country—A Dual‐Center Pilot Program. Helicobacter. 2025. doi:10.1111/hel.70061
BibTeX
@article{Mourato2025,
author = {Mourato, M B and Pratas, N and Branco Pereira, A and Costa Pinto, F and Dinis, R and Fronteira, I and Areia, M},
title = {Gastric Cancer Endoscopic Screening in an Intermediate‐Risk Country—A Dual‐Center Pilot Program},
journal = {Helicobacter},
year = {2025},
doi = {10.1111/hel.70061}
}
EUVIMED